| Literature DB >> 30416630 |
Hicham Mansour1, Mireille Feghali2, Nadine Saleh3, Mona Zeitouny4.
Abstract
OBJECTIVES: Explore antibiotic use, assess conformity with evidence-practice guidelines, and describe knowledge and attitudinal factors among Lebanese dentists.Entities:
Keywords: Antibiotic Prophylaxis; Attitudes; Dentists; Guideline Adherence; Health Knowledge; Inappropriate Prescribing; Lebanon; Penicillins; Practice; Professional Practice; Streptomyces; Surveys and Questionnaires
Year: 2018 PMID: 30416630 PMCID: PMC6207361 DOI: 10.18549/PharmPract.2018.03.1272
Source DB: PubMed Journal: Pharm Pract (Granada) ISSN: 1885-642X
Professional Characteristics of Participating Dentists
| N | % | |||||
|---|---|---|---|---|---|---|
| Main Consultation Region (n=322) | ||||||
| Mount-Lebanon | 177 | 55.0 | ||||
| Beirut | 65 | 20.2 | ||||
| South (including Nabatiyeh) | 42 | 13.1 | ||||
| Bekaa | 35 | 10.9 | ||||
| North | 3 | 0.9 | ||||
| Primary dental qualification (n=318) | ||||||
| Lebanon | 192 | 60.4 | ||||
| Other countries | 126 | 39.6 | ||||
| Years in practice (n=314) | ||||||
| < 1-5 years | 21 | 6.7 | ||||
| 5-10 years | 43 | 13.7 | ||||
| > 10 years | 250 | 79.6 | ||||
| Specialty (n=309) | ||||||
| General practitioner | 134 | 43.4 | ||||
| Oral surgeon | 33 | 10.7 | ||||
| Endodontic | 30 | 9.7 | ||||
| Implant surgeon | 28 | 9.1 | ||||
| Pediatric dentist | 22 | 7.1 | ||||
| Orthodontist | 21 | 6.8 | ||||
| Restorative Dentist | 12 | 3.9 | ||||
| Prosthodontics | 15 | 4.9 | ||||
| Periodontics | 9 | 2.9 | ||||
| Other | 5 | 1.6 | ||||
| Postgraduate qualification (n=315) | ||||||
| None | 134 | 42.5 | ||||
| Master’s degree | 114 | 36.2 | ||||
| University Diploma | 49 | 15.6 | ||||
| PhD | 18 | 5.7 | ||||
| Country where postgraduate qualification was obtained (n=169) | ||||||
| Lebanon | 132 | 78.1 | ||||
| Western Europe | 23 | 13.6 | ||||
| Eastern Europe | 8 | 4.7 | ||||
| USA | 5 | 3.0 | ||||
| Egypt | 1 | 0.6 | ||||
| Practice setting (n=322) | ||||||
| Private Clinic | 308 | 95.7 | ||||
| Private Hospital | 1 | 0.3 | ||||
| Public Hospital | 1 | 0.3 | ||||
| Mixt | 12 | 3.7 | ||||
| Continuing education source (n=314) | ||||||
| None | 13 | 4.1 | ||||
| National conferences | 154 | 49.0 | ||||
| National and international conferences and continuing education lectures | 99 | 31.5 | ||||
| International conferences | 33 | 10.5 | ||||
| Continuing education lectures | 15 | 4.8 | ||||
| Guidelines followed for prescribing prophylaxis regimens for infective endocarditis among susceptible patients (n=315) | ||||||
| Do not know | 103 | 32.7 | ||||
| Guidelines provided during dental qualification years | 84 | 26.7 | ||||
| American Health Association (AHA) | 73 | 23.2 | ||||
| Agence Française de Sécurité Sanitaire des Produits de Santé (Afssaps) | 33 | 10.5 | ||||
| National Institute for Clinical Excellence (NICE) and the British Society for Antimicrobial Chemotherapy (BSAC) | 21 | 6.7 | ||||
| Other | 1 | 0.3 | ||||
| Attending at least 1 lecture relating to the use of antibiotics in dental medicine during the past 5 years (n=316) | 154 | 48.7 | ||||
| Reading at least 1 journal article relating to the use of antibiotics in dental medicine during the past 5 years (n=314) | 157 | 50.0 | ||||
| Number of patients per week (n=233) | 10 | 240 | 48.00 | 30.00 | 53.71 | 35.81 |
| Number of prescribed systemic antibiotics courses per week (n=260) | 0 | 100 | 5.00 | 7.00 | 8.80 | 11.73 |
| Frequency of antibiotic prescription per dental consultation (%) (n=274) | 0 | 100 | 10.00 | 12.50 | 17.51 | 18.32 |
Valid percentages are reported, Min: minimum; Max: maximum; IQR: interquartile range; SD: standard deviation
Attitude of participating dentists toward antibiotic prescribing
| N | % | ||
|---|---|---|---|
| First choice antibiotic prescribed to patients allergic to penicillin (n=289) | Spiramycin + Metronidazole | 86 | 29.8 |
| Spiramycin | 69 | 23.9 | |
| Unspecified Macrolides | 35 | 12.1 | |
| Clindamycin | 34 | 11.8 | |
| Clarithromycin | 33 | 11.4 | |
| Amoxicillin | 11 | 3.8 | |
| Cephalosporin | 10 | 3.5 | |
| Amoxicillin + Clavulanic acid | 6 | 2.1 | |
| Metronidazole | 2 | 0.7 | |
| Cetirizine | 1 | 0.3 | |
| Ciprofloxacin | 1 | 0.3 | |
| Sulphamides + Diamonopyrimidine | 1 | 0.3 | |
| First choice antibiotic prescribed to a pregnant woman (n=275) | Amoxicillin + Clavulanic acid | 86 | 31.3 |
| Spiramycin | 53 | 19.2 | |
| Amoxicillin | 44 | 16.0 | |
| Spiramycine + Metronidazole | 8 | 2.9 | |
| Clindamycin | 4 | 1.5 | |
| Azithromycin | 2 | 0.7 | |
| Cephalosporin | 2 | 0.7 | |
| Aminosides | 1 | 0.4 | |
| Penicillines or Spiramycine + Metronidazole | 1 | 0.4 | |
| Referral to gynecologist | 74 | 26.9 | |
| First choice antibiotic prescribed to a breastfeeding woman (n=274) | Amoxicillin + Clavulanic acid | 85 | 31.1 |
| Spiramycin | 51 | 18.6 | |
| Amoxicillin | 42 | 15.3 | |
| Spiramycine + Metronidazole | 9 | 3.3 | |
| Clindamycin | 5 | 1.8 | |
| Cephalosporin | 2 | 0.7 | |
| Gentamycin | 1 | 0.4 | |
| Penicillines or Spiramycine + Metronidazole | 1 | 0.4 | |
| Referral to gynecologist | 78 | 28.5 | |
| Frequency of referring cardiac patients to their physician when necessary (n=321) | Always | 255 | 79.4 |
| Sometimes | 58 | 18.1 | |
| Never | 8 | 2.5 | |
| Enquire if the patient is currently taking an antibiotic before proceeding to consultation (n=320) | Always | 278 | 86.9 |
| Often | 24 | 7.5 | |
| Sometimes | 14 | 4.4 | |
| Never | 4 | 1.3 | |
| Attitude regarding a patient who has already taken antibiotics before consultation (n=154) | Continue antibiotic course | 85 | 55.2 |
| Action depends on the antibiotic | 32 | 20.8 | |
| Change the antibiotic | 19 | 12.3 | |
| Action depends on time (change if antibiotic taken during last month) | 8 | 5.2 | |
| Discontinue antibiotic course | 7 | 4.5 | |
| Continue antibiotic course and add vitamins | 2 | 1.3 | |
| Increase the dose | 1 | 0.6 | |
| Feeling pressure from patients to prescribe antibiotics (n=319) | Always | 27 | 8.5 |
| Often | 43 | 13.5 | |
| Sometimes | 72 | 22.6 | |
| Never | 177 | 55.0 | |
| Factor(s) mostly influencing antibiotics prescribing behavior (n=321) | Previous antibiotic experience | 261 | 81.3 |
| Comorbidities of the patient | 174 | 54.2 | |
| Socio-economic status of the patient | 103 | 32.1 | |
| Price of the antibiotic | 101 | 31.5 | |
| Samples availability | 44 | 13.7 | |
| Medical representative visits | 37 | 11.5 | |
Valid percentages are reported;
Percentages may add up to more than 100%, due to multiple possible answers
Prophylactic and Curative Antibiotic Prescribing Practices of Participating Dentists and Conformity with Evidence-Practice Guidelines
| N (%) | No | Yes all patients | Yes High-risk patients‡ | Indication | Conformity with evidence-practice guidelines* | ||
|---|---|---|---|---|---|---|---|
| Type | Dose | Duration | |||||
| Among those who provided a correct answer to indication | |||||||
| Bone graft (n=180) | 84 (46.7) | 87 (48.3) | 9 (5) | 87 (48.3) | 67 (77.0) | 54 (62.1) | 3 (3.4) |
| Braces (n=30) | 20 (66.7) | 0 (0) | 10 (33.3) | 20 (66.7) | NA | ||
| Crown (n=306) | 287 (93.8) | 0 (0) | 19 (6.2) | 287 (93.8) | NA | ||
| Crown lengthening (n=240) | 165 (68.8) | 50 (20.8) | 25 (10.4) | 25 (10.4) | 2 (8.0) | 1 (4.0) | 0 (0) |
| Extraction mandibular tooth (n=294) | 103 (35) | 138 (46.9) | 53 (18) | 138 (46.9) | 84 (60.9) | 38 (27.5) | 4 (2.9) |
| Extraction maxillary tooth (n=293) | 106 (36.2) | 138 (47.1) | 49 (16.7) | 138 (47.1) | 91 (65.9) | 49 (35.5) | 4 (2.9) |
| Flap surgery (n=166) | 101 (60.8) | 49 (29.5) | 16 (9.6) | 101 (60.8) | NA | ||
| Frenectomy (n=249) | 188 (75.5) | 39 (15.7) | 22 (8.8) | 22 (8.8) | 4 (18.2) | 2 (9.1) | 1 (4.5) |
| Germectomy (n=209) | 107 (51.2) | 80 (38.3) | 22 (10.5) | 80 (38.3) | 51 (63.8) | 26 (32.5) | 2 (2.5) |
| Gingivectomy (n=293) | 225 (76.8) | 41 (14) | 27 (9.2) | 27 (9.2) | 4 (14.8) | 2 (7.4) | 1 (3.7) |
| Implant (n=228) | 95 (41.7) | 127 (55.7) | 6 (2.6) | 6 (2.6) | 2 (33.3) | 1 (16.7) | 1 (16.7) |
| Interim care (n=306) | 296 (96.7) | 0 (0) | 10 (3.3) | 296 (96.7) | NA | ||
| Intraligamentary local anesthesia (n=311) | 298 (95.8) | 3 (1) | 13 (4.2) | 13 (4.2) | 2 (15.4) | 2 (15.4) | 0 (0) |
| Local anesthesia (n=311) | 285 (91.6) | 13 (4.2) | 13 (4.2) | 285 (91.6) | NA | ||
| Necrotic tooth (n=299) | 188 (62.9) | 84 (28.1) | 27 (9) | 188 (62.9) | NA | ||
| Prosthesis (n=306) | 295 (96.4) | 0 (0) | 11 (3.6) | 296 (96.4) | NA | ||
| Restoration (n=306) | 296 (96.7) | 0 (0) | 10 (3.3) | 296 (96.7) | NA | ||
| Scaling (n=309) | 215 (69.6) | 7 (2.3) | 87 (28.2) | 215 (69.6) | NA | ||
| 209 (68.5) | 46 (15.1) | 50 (16.4) | 50 (16.4) | 23 (46.0) | 17 (34.0) | 1 (2.0) | |
| 126 (83.4) | 18 (11.9) | 7 (4.6) | 7 (4.6) | 0 (0) | 0 (0) | 0 (0) | |
| Agressive periodontitis (n=268) | 77 (28.7) | 176 (65.7) | 15 (5.6) | 176 (65.7) | 90 (51.1) | 47 (26.7) | 60 (34.1) |
| Apical abscess (n=306) | 97 (31.7) | 192 (62.7) | 17 (5.6) | 17 (5.6) | 9 (52.9) | 0 (0) | 1 (5.9) |
| Bacterial stomatitis (n=142) | 104 (73.2) | 38 (26.8) | 0 (0) | 38 (26.8) | 24 (63.2) | 21 (55.3) | 17 (44.7) |
| Cellulitis (n=253) | 53 (20.9) | 174 (68.8) | 26 (10.3) | 174 (68.8) | 122 (70.1) | 0 (0) | 67 (38.5) |
| Chronic periodontitis (n=289) | 213 (73.7) | 55 (19) | 21 (7.3) | 213 (73.7) | NA | ||
| Combined lesion (n=293) | 173 (59) | 117 (39.9) | 3 (1) | 173 (59) | NA | ||
| Fistula (n=285) | 137 (48.1) | 127 (44.6) | 21 (7.4) | 127 (44.6) | 77 (60.6) | 39 (30.7) | 58 (45.7) |
| Gingivitis (n=297) | 246 (82.8) | 37 (12.5) | 14 (4.7) | 246 (82.2) | NA | ||
| Maxillary sinusitis (n=159) | 104 (65.4) | 48 (30.2) | 7 (4.4) | 48 (30.3) | 36 (75.0) | 15 (31.3) | 18 (37.5) |
| Osteomyelitis (n=170) | 68 (40) | 90 (52.9) | 12 (7.1) | 90 (52.9) | 78 (86.7) | 61 (67.8) | 35 (38.9) |
| Periapical abscess (n=305) | 77 (25.2) | 203 (66.6) | 25 (8.2) | 25 (8.2) | 8 (32) | 0 (0) | 1 (4.0) |
| Periimplantitis (n=170) | 100 (58.8) | 51 (30) | 19 (11.2) | 19 (11.2) | 0 (0) | 0 (0) | 0 (0) |
| Periodontal abscess (n=284) | 75 (26.4) | 192 (67.6) | 17 (6) | 17 (6) | 8 (47.1) | 4 (23.5) | 4 (23.5) |
| Pulpitis (n=305) | 269 (88.2) | 27 (8.9) | 9 (3) | 269 (88.2) | NA | ||
| Salivary gland infection (n=136) | 113 (83.1) | 23 (16.9) | 0 (0) | 23 (16.9) | 20 (87) | 18 (78.3) | 9 (39.1) |
| Tooth decay (n=311) | 304 (97.7) | 5 (1.6) | 2 (0.6) | 304 (97.7) | NA | ||
NA: not applicable.
Dentists describing cases as referred or rarely seen were excluded;
Valid percentages are reported;
Selected patients with cardiac conditions; compromised immunity; shunts, indwelling vascular catheters, medical devices; and prosthetic joints (5-9).
Percentage of prophylactic antibiotics regimens for cardiac patients (n=103)
| types of prophylactic antibiotics | |
|---|---|
| Amoxicillin | 52.5 |
| Amoxicillin and Clavulanic acid | 36.4 |
| Unspecified penicillin | 6.1 |
| Spyramicin | 3.0 |
| Amoxicilin or Spyramicin | 1.0 |
| Depends on the case | 1.0 |
| doses of prophylactic antibiotics | |
| 2 g | 63.9 |
| 3 g | 9.8 |
| Flash dose | 8.2 |
| 50 mg/Kg | 4.9 |
| 1-2 g | 3.3 |
| 2-3 g | 3.3 |
| Other | 6.6 |
| timing of antibiotics prophylaxis | |
| 1 hour before procedure | 34.0 |
| 1 hour before and after procedure | 10.6 |
| 1 hour before and 6 hours after procedure | 7.4 |
| 1 hour before and 7 days after procedure | 6.4 |
| 2 hours before procedure | 6.4 |
| 1 day before procedure | 4.3 |
| 2 days before procedure | 3.2 |
| 3 days before procedure | 3.2 |
| Other | 24.5 |
*Valid percentages are reported
Knowledge of antibiotic prescribing of participating dentists
| N | % | |
|---|---|---|
| Prosthetic cardiac valves (n=140) | 135 | 96.4 |
| Rheumatic heart disease (n=131) | 26 | 19.8 |
| Mitral valve prolapsed with valvular regurgitation (n=124) | 16 | 12.9 |
| Previous infective endocarditis (n=127) | 102 | 80.3 |
| Previous coronary artery bypass graft surgery (n=140) | 70 | 50.0 |
| Hypertrophic cardiomyopathy (n=147) | 84 | 26.1 |
| Intravascular cardiac pacemakers (n=147) | 49 | 33.3 |
| Myocardial infarct in the last 6 months (n=125) | 26 | 20.8 |
| Cardiac transplantation recipients who develop cardiac valvulopathy (n=131) | 65 | 49.6 |
| Unrepaired cyanotic heart disease (n=134) | 57 | 42.5 |
| Recently placed coronary stents (n=144) | 30 | 20.8 |
| Atrial septal defect after 6 months of repair (n=134) | 59 | 44.0 |
| Ventricular septal defect with repair (n=140) | 56 | 40.0 |
| Patent ductus arteriosus (n=140) | 56 | 40.0 |
| Cardiac catheterization without stents (less than 1 year) (n=183) | 61 | 43.9 |
| Human immunodeficiency virus (n=155) | 90 | 58.1 |
| Neutropenia (n=132) | 51 | 38.6 |
| Cancer chemotherapy (n=136) | 81 | 59.6 |
| Diabetes (n=245) | 188 | 76.7 |
| Hematopoietic stem cell or solid organ transplantation (n=133) | 56 | 42.1 |
| Bisphosphonate therapy (n=173) | 62 | 35.8 |
| Chronic steroid usage (n=172) | 91 | 52.9 |
| Asplenism or status post splenectomy (n=175) | 69 | 39.4 |
| Patients with prosthetic joints (n=173) | 16 | 9.2 |
Valid percentages are reported
Mean Knowledge Scores (%) by Sociodemographic and Professional Characteristics
| Prophylaxis for cardiac conditions (n=76) | Prophylaxis for non-cardiac conditions (n=85) | Side effects of antibiotics (n=322) | |
|---|---|---|---|
| Overall score | 46.75 (14.82) | 39.21 (33.09) | 20.27 (18.77) |
| 24-34 | 53.33 (12.34) | 39.35 (35.13) | 23.80 (17.77) |
| 35-50 | 43.95 (15.27) | 43.46 (31.23) | 19.23 (18.46) |
| >50 | 45.83 (15.21) | 34.78 (33.55) | 19.95 (19.95) |
| p-value | 0.13 | 0.62 | 0.30 |
| Male | 46.02 (15.35) | 40.50 (33.36) | 19.17 (18.65) |
| Female | 50.00 (12.19) | 35.74 (32.81) | 22.50 (18.90) |
| p-value | 0.36 | 0.55 | 0.13 |
| Beirut | 44.10 (7.47) | 23.14 (28.73) | 13.40 (10.97) |
| Other | 47.30 (15.91) | 45.53 (32.75) | 22.01 (19.92) |
| p-value | 0.27 | 0.003 | <0.001 |
| < 1-5 years | 56.19 (13.80) | 37.03 (41.94) | 25.85 (15.39) |
| 5-10 years | 47.33 (19.98) | 40.00 (32.74) | 21.26 (18.00) |
| > 10 years | 45.63 (13.89) | 39.65 (31.91) | 20.00 (19.28) |
| p-value | 0.20 | 0.97 | 0.38 |
| General practitioner | 47.13 (15.07) | 30.82 (31.65) | 20.25 (14.47) |
| Other | 46.26 (14.71) | 44.03 (33.22) | 20.28 (21.35) |
| p-value | 0.80 | 0.07 | 0.98 |
| In Lebanon | 52.72 (13.37) | 45.89 (31.91) | 21.94 (19.87) |
| Outside Lebanon | 42.17 (14.38) | 32.73 (33.43) | 18.14 (16.89) |
| p-value | 0.002 | 0.07 | 0.06 |
| No | 47.23 (15.07) | 30.82 (31.65) | 20.25 (14.47) |
| Yes | 46.45 (14.90) | 46.18 (32.91) | 20.59 (21.52) |
| p-value | 0.84 | 0.04 | 0.86 |
| No | 46.66 (11.54) | 24.07 (32.52) | 18.68 (10.72) |
| Yes | 47.04 (15.26) | 43.07 (32.91) | 20.45 (19.09) |
| p-value | 0.96 | 0.17 | 0.58 |
| 0-50 | 46.23 (18.13) | 44.14 (34.19) | 21.88 (19.98) |
| 51-100 | 49.16 (12.38) | 48.41 (31.60) | 27.60 (21.85) |
| >100 | 42.85 (14.32) | 68.88 (27.66) | 19.64 (11.51) |
| p-value | 0.67 | 0.29 | 0.13 |
| 0-10 | 45.71 (15.05) | 40.54 (34.36) | 21.36 (17.17) |
| >10 | 49.85 (16.43) | 41.58 (32.71) | 21.65 (20.82) |
| p-value | 0.30 | 0.89 | 0.90 |